KENTUCKY HEART FOUNDATION INC

EIN: 260791997 501(c)(3) Medical Research

ASHLAND, KY

Total Revenue
$660
Total Expenses
$62,368
Total Assets
$569,431
Net Assets
$568,374
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2007
Legal Domicile
KY
Principal Officer
SARA MARKS
Phone
6063241544
Tax Period
2022-10-01 to 2023-06-30

KENTUCKY HEART FOUNDATION INC, founded in 2007, is a micro nonprofit in the Medical Research sector that reported $660 in total revenue in fiscal year 2022. Revenue decreased 17% compared to the prior year. Expenses of $62K exceeded revenue, resulting in a 9350% operating deficit.

Mission

TO REDUCE THE IMPACT OF HEART AND VASCULAR DISEASE THROUGH RESEARCH, PREVENTION, AND EDUCATION. VISION: TO IMPROVE THE QUALITY OF LIFE BY REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE.

Program Service Accomplishments

Program 1
Expenses: $62,368

THE KENTUCKY HEART FOUNDATION (KHF) WAS FOUNDED IN MAY 2007. THE KHF IS A NONPROFIT ORGANIZATION THAT WORKS WITH OTHER HEALTHCARE PROVIDERS TO ADDRESS HEART AND VASCULAR DISEASE IN THIS REGION. IN...

Read more

THE KENTUCKY HEART FOUNDATION (KHF) WAS FOUNDED IN MAY 2007. THE KHF IS A NONPROFIT ORGANIZATION THAT WORKS WITH OTHER HEALTHCARE PROVIDERS TO ADDRESS HEART AND VASCULAR DISEASE IN THIS REGION. IN CONJUNCTION WITH THESE OTHER PROVIDERS THE KHF WORKS ON THE FOLLOWING: IMPROVING THE QUALITY OF LIFE IN THE APPALACHIAN REGION REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE ADVANCING MEDICAL SCIENCE THROUGH INTEGRATED, INNOVATIVE AND PROGRESSIVE PROGRAMS IN RESEARCH, EDUCATION, PREVENTION, EARLY DETECTION, AND IMPROVED PATIENT CARE CREATING ACCESS TO CUTTING-EDGE TECHNOLOGY DEVELOPING A FORUM FOR RESEARCH THAT WILL BENEFIT PATIENTS THROUGHOUT THE NATIONKHF'S VISION IS TO IMPROVE THE QUALITY OF LIFE BY REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE. OUR MISSION IS TO REDUCE THE IMPACT OF HEART AND VASCULAR DISEASE THROUGH RESEARCH, PREVENTION AND EDUCATION. PRIORITIES INCLUDE: RESEARCH, EDUCATION, PREVENTION, FINANCE, AND CULTURE.THE KHF SERVES APPALACHIAN COUNTIES COVERING PARTS OF EASTERN KENTUCKY, SOUTHEASTERN OHIO AND WESTERN WEST VIRGINIA. THESE COUNTIES ARE SOME OF THE MOST IMPOVERISHED IN THE AREA. ALSO KNOWN AS THE CORONARY VALLEY, THE AREA GOT THIS NAME BECAUSE OF THE HIGH MORTALITY RATES FROM CARDIOVASCULAR DISEASE AND THE POOR HEALTH HABITS OF ITS RESIDENTS. HEART DISEASE IS THE NUMBER ONE KILLER OF ADULTS, WITH MORTALITY RATES VERY HIGH COMPARED TO STATE AND NATIONAL DATA. RESIDENTS OF THE AREA HAVE LOW ACADEMIC ACHIEVEMENT; HIGH SMOKING RATES; LACK OF PHYSICAL EXERCISE; AND ONE OF THE HIGHEST OBESITY RATES IN THE NATION. ALL COMBINED, IT IS NO WONDER THAT CARDIOVASCULAR DISEASE IS THE NUMBER ONE HEALTH THREAT FOR ADULTS IN THE AREA. WITH A FOCUS ON IMPROVING THE CARDIOVASCULAR OUTCOMES FOR THE AREA'S RESIDENTS. PARTNERING WITH PROGRESSIVE CARDIOLOGISTS, CARDIOTHORACIC SURGEONS, VASCULAR SURGEONS, AND INTERVENTIONAL RADIOLOGISTS AT KING'S DAUGHTERS PROVIDES THE KHF THE OPPORTUNITY TO ANSWER IMPORTANT CLINICAL RESEARCH QUESTIONS IN ORDER TO IMPROVE CARE FOR OUR PATIENTS FOR NOW AND GENERATIONS TO COME.THE KHF WORKS WITH DEVICE AND DRUG MANUFACTURERS TO BRING NEW RESEARCH PROGRAMS TO THE REGION. KHF HAS BEEN AND CONTINUES TO BE FOCUSED ON RESEARCH TO IMPROVE THE ASSESSMENT, PREVENTION, AND TREATMENT OF ACUTE CORONARY SYNDROME, MYOCARDIAL INFARCTION, DUAL ANTIPLATELET THERAPY, ATRIAL FIBRILLATION, HEART FAILURE, STROKE AND VASCULAR DISEASE, CHILDHOOD AND ADULT OBESITY, AND LUNG HEALTH.THE KHF HAS THREE PRIMARY PROGRAM-RELATED FOCUSED AREAS: RESEARCH, EDUCATION, AND PREVENTION. 1) RESEARCH: DURING FY2023, THE KHF CONTINUED TO FOCUS ON RESEARCH FOLLOWING UP TO 25 PATIENTS IN ACTIVE CLINICAL TRIALS, INCLUDING:- IN.PACT AV ACCESS STUDY: RANDOMIZED STUDY OF IN.PACT AV ACCESS PACLITAXEL-COATED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON VS. STANDARD PTA FOR THE TREATMENT OF OBSTRUCTIVE LESIONS IN THE NATIVE ARTERIOVENOUS DIALYSIS FISTULAE (AVF)- RANGER II SFA: A 3:1 RANDOMIZED TRIAL COMPARING THE BOSTON SCIENTIFIC RANGER PACLITAXEL COATED BALLOON VS. STANDARD BALLOON ANGIOPLASTY FOR THE TREATMENT OF SUPERFICIAL FEMORAL ARTERIES (SFA) AND PROXIMAL POPLITEAL ARTERIES (PPA).- WAVE: PROSPECTIVE, RANDOMIZED, CONTROLLED, MULTICENTER STUDY COMPARING THE MERIT WRAPSODY ENDOVASCULAR STENT GRAFT TO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TREATMENT OF VENOUS OUTFLOW CIRCUIT STENOSIS OR OCCLUSION IN HEMODIALYSIS PATIENTS.THE FOUNDATION CONTINUALLY LOOKS FOR TRIALS AND STUDIES THAT WILL BE OF BENEFIT TO OUR PATIENTS AND OUR PHYSICIANS. 2) EDUCATION: THE KHF OFFERS BOTH HEALTHCARE PROVIDER AND COMMUNITY EDUCATION AS PART OF ITS SCOPE OF WORK. DURING FY2023, THE KHF HOSTED CONTINUING MEDICAL EDUCATION: THE KHF IS ACCREDITED BY THE KENTUCKY MEDICAL ASSOCIATION TO PROVIDE CONTINUING MEDICAL EDUCATION, PROVIDING EDUCATIONAL PROGRAMMING FOR PHYSICIANS AFFILIATED WITH KING'S DAUGHTERS MEDICAL CENTER. DURING THE YEAR, CONTINUING MEDICAL EDUCATION PROGRAMS AND REGULAR SCHEDULED SERIES WERE HOSTED WHILE NUMEROUS OTHER DISCIPLINES (NURSE PRACTITIONERS, NURSES, PHYSICAL THERAPISTS, PHYSICIAN ASSISTANTS, ETC.) ALSO TOOK ADVANTAGE OF CME PROGRAMS.3) PREVENTION: IN PARTNERSHIP WITH KING'S DAUGHTERS COMMUNITY HEALTH TEAM, WE FOCUS ON EARLY DETECTION OF CARDIOVASCULAR RISK FACTORS AND PROPER TREATMENT ARE CRITICAL TO REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE. PROGRAMS AND SCREENINGS INCLUDE FREE HEALTHY HEART SCREENINGS, LOW COST HEART AND VASCULAR SCREENINGS AND LOW COST BLOOD PROFILES THROUGHOUT THE REGION. THIS OUTREACH EFFORT HELPED COMMUNITY MEMBERS UNDERSTAND THEIR PERSONAL RISKS OF HEART DISEASE AND PROVIDED LOW-COST, EASY ACCESS TO REGULAR BLOOD WORK TO MONITOR BLOOD SUGAR, CHOLESTEROL AND OTHER KEY METABOLIC MEASURES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $375
Program Service Revenue $0
Investment Income $285
Other Revenue $0
TOTAL REVENUE $660

Expense Breakdown

Grants Paid $0
Salaries & Benefits $58,121
Fundraising Expenses $0
Program Expenses $62,368
Other Expenses $4,247
TOTAL EXPENSES $62,368

Year-over-Year Comparison

2022 2021 Change
Revenue $660 $799 -0.2%
Expenses $62,368 $106,345 -0.4%
Net Income $-61,708 $-105,546 -0.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
10
Independent Members
10
Employees
N/A
Volunteers
13

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$5,783,585
Total Directors
11
$0
Key Employees
2
$1,093,854
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
DAVID JONES CHAIRMAN 0.25
Officer Director
$0 $0 $0
DR MARK NEWMAN BOARD VICE-CHAIRMAN (UNTIL 12/31/22) 0.25
Officer Director
$0 $0 $0
STEPHEN ADDINGTON DIRECTOR 0.25
Director
$0 $0 $0
MARK BIRDWHISTELL DIRECTOR 0.25
Director
$0 $0 $0
TOM BURNETTE DIRECTOR 0.25
Director
$0 $0 $0
CRAIG COLLINS DIRECTOR 0.25
Director
$0 $0 $0
ERIC MONDAY DIRECTOR 0.25
Director
$0 $0 $0
JOHN STEWART DIRECTOR 0.25
Director
$0 $0 $0
PENNY COX DIRECTOR 0.25
Director
$0 $0 $0
GINA DUGAS DIRECTOR 0.25
Director
$0 $0 $0
ROBERT DIPAOLA DIRECTOR 0.25
Director
$0 $0 $0
SHERYL MAHANEY UNTIL 113022 SECRETARY, VP/CHIEF LEGAL OFFICER 1.25
Officer
$0 $8,395 $1,526,527
AUTUMN MCFANN TREASURER, SR VP/CFO/CAO 1.25
Officer
$0 $131,808 $2,028,936
SARA MARKS PRESIDENT/CEO (BEG. 1/1/23) 1.25
Officer
$0 $142,949 $1,987,783
AMY SAUNDERS ASSISTANT SECRETARY (STARTING 12/1/22) 0.25
Officer
$0 $12,371 $240,339
KRISTIE WHITLATCH PRESIDENT/CEO (10/1/22-12/31/22) 1.25
Officer
$0 $0 $0
STEVEN CLIFTON SECRETARY (STARTING 12/1/22) 0.25
Officer
$0 $0 $0
CHARBEL SALEM MD MEDICAL DIRECTOR 10.00
Key Emp
$0 $94,176 $876,306
PATRICIA CORBITT EXECUTIVE DIRECTOR 2.00
Key Emp
$0 $32,109 $217,548
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 No data No data No data No data
2023 $660 $62,368 $569,431 $-61,708
2022 $799 $106,345 $569,146 $-105,546
2021 $4,678 $165,862 $569,027 $-161,184
2020 $17,794 $135,933 $572,012 $-118,139
2019 $82,733 $98,643 $568,239 $-15,910
2018 $77,764 $138,982 $560,784 $-61,218
Explore More Nonprofits
Top 100 Nonprofits in Kentucky Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare KENTUCKY HEART FOUNDATION INC with other nonprofits in Kentucky and across the country.